Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial

被引：0

作者：

Isenberg, David ^{[1
]}

Li, Yong ^{[2
]}

Wax, Stephen ^{[3
]}

Wofsy, David ^{[4
]}

Gordon, Caroline ^{[5
]}

机构：

[1] UCL, Ctr Rheumatol, London WC1E 6BT, England

[2] EMD Serono Inc, R&D Global BioStat, Billerica, MA USA

[3] EMD Serono Inc, Global Clin Dev, Rockland, MA USA

[4] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA

[5] Univ Birmingham, Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England

来源：

ARTHRITIS RESEARCH & THERAPY | 2014年 / 16卷

关键词：

Systemic Lupus Erythematosus; Vasculitis; Systemic Lupus Erythematosus Patient; Systemic Lupus Erythematosus Disease; Active Systemic Lupus Erythematosus;

D O I：

10.1186/ar4669

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A53

引用

页数：2